RECQL4 and hepatocellular carcinoma: Mechanistically, we demonstrated that HCC‐derived RECQL4 can act as a major immune controller in the TME by suppressing cGAS‐STING activation in radiation‐induced DCs and reducing the release of IFN‐I in CD8 T cells.